J3262 — Tocilizumab 400 Mg/20 Ml (20 Mg/ml) Intravenous Solution
$12,748
All-payer median here
$11,154
Cash / self-pay here
20
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.